# DocMorris financial restructuring and market performance

> Live situation record from CLSTR: https://clstr.news/situations/docmorris-financial-restructuring-and-market-performance
> Updated: 2026-09-30T10:39:17.000Z. Sources: 5. Developments: 2.

DocMorris AG has undertaken strategic financial restructuring and improved its market outlook. In early September 2026, the company completed a private placement of approximately CHF 100 million in convertible bonds due in 2031. This move was intended to extend the company’s financing horizon, reduce its coupon rate from 3.0% to 1.5%, and proactively manage share dilution.

By late September 2026, DocMorris shares reached a 52-week high of 13.18 CHF following upwardly adjusted financial forecasts. Management increased external revenue growth expectations to between 9 and 13 percent and narrowed the projected adjusted EBITDA loss range. The company is currently targeting an operational turning point, aiming for adjusted EBITDA break-even in the second half of the fiscal year and cash flow break-even by 2027.

## Timeline

### 2026-09-30: DocMorris shares reach 52-week high amid improved forecasts

DocMorris shares hit a 52-week high of 13.18 CHF as the company raised its growth forecasts and targets an EBITDA break-even in the second half of the fiscal year.

3 sources. https://clstr.news/cluster/docmorris-shares-reach-52-week-high-amid-improved-forecasts

### 2026-09-09: DocMorris completes CHF 100 million convertible bond placement

DocMorris AG has completed a CHF 100 million private placement of convertible bonds due in 2031, extending its financing maturity and reducing its coupon rate to 1.5%.

2 sources. https://clstr.news/cluster/docmorris-completes-chf-100-million-convertible-bond-placement

---
Cite as: DocMorris financial restructuring and market performance. CLSTR, https://clstr.news/situations/docmorris-financial-restructuring-and-market-performance